Scientists Have Discovered A New Method Of Detecting Cancer

Scientists Have Discovered A New Method Of Detecting Cancer.
A callow try marketed as an surrogate to a mammogram for breast cancer detection is not an telling screening TOOL, US health officials say. With the nipple aspirate test, a heart pump collects variable from a woman's nipple. The fluid is then examined for offbeat and potentially cancerous cells increase. The test is advertised as easier, more easy and less painful than mammograms.

However, there is no proof to support claims that the proof can detect breast cancer, said Dr David Lerner, a medical dick at the US Food and Drug Administration and a core imaging specialist product. "FDA's concern is that the nipple aspirate analysis is being touted as a standalone tool to screen for and determine breast cancer as an alternative to mammography," Lerner said in an energy news release.

So "Our fear is that women will forgo a mammogram and have this examination instead". Skipping a mammogram could put a woman's fettle and life at risk if breast cancer goes undetected, Lerner warned. He said there is no ordered evidence that the nipple aspirate test, when reach-me-down on its own, is an effective screening tool for tit cancer or any other medical condition.

The test is still being studied to determine if it might be helpful in combination with other methods to screen for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of bust cancer. Mammography is still the gold standard".

In October, 2013, Atossa Genetics pulled its nipple aspirate investigation - called the ForeCYTE Breast Health Test - off the supermarket after being warned by the FDA that its claims about the trial were unsubstantiated. The business claimed the probe was "literally a Pap aspersion for breast cancer". Pap smears are a standard evaluate for cervical cancer.

And Women who have had a nipple aspirate test as a profile of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should bull to their doctor about whether additional tests are needed, the FDA said. One in eight US women will exhibit boob cancer in her lifetime vigrx box. The disease is the split second leading cancer killer of women in the country.